Growth Investing in 2025 — Where Will Value Accrue in Later-Stage Medtech? | LSI USA '25

This panel took place at LSI USA '25 Emerging Medtech Summit in Dana Point, CA.

Industry experts from Signet Healthcare Partners, Buenavista Equity Partners, Windham Capital Partners, and more discuss key trends and pinpoint where investors will find value in later-stage medtech by 2025.

This panel featured:

Brian Rowett — Goldman Sachs

Ashley Friedman — Signet Healthcare Partners

Bibi Sattar Marques — Buenavista Equity Partners

Craig Matturo — 1315 Capital

David Kereiakes — Windham Capital Partners

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

Follow us on social!

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw